Jade Biosciences, Inc.
Clinical trials sponsored by Jade Biosciences, Inc., explained in plain language.
-
New hope for kidney patients: JADE101 trial launches
Disease control Not yet recruitingThis study tests a new drug, JADE101, in 30 adults with IgA nephropathy, a kidney disease. The goal is to see if the drug is safe and can reduce protein in the urine, a sign of kidney damage. Participants must be on stable standard care before joining.
Phase: PHASE2 • Sponsor: Jade Biosciences, Inc. • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
New RA drug JADE201 enters first human safety trial
Symptom relief Not yet recruitingThis early-stage study tests a new drug, JADE201, in 36 adults with rheumatoid arthritis. The main goal is to see if single doses are safe and how the body processes the drug. Participants will receive either JADE201 or a placebo by injection, and researchers will monitor side ef…
Phase: PHASE1 • Sponsor: Jade Biosciences, Inc. • Aim: Symptom relief
Last updated May 17, 2026 08:01 UTC
-
New drug JADE101 tested in healthy volunteers – no cure expected
Knowledge-focused Not yet recruitingThis early-phase study tests a single dose of JADE101 in 40 healthy Japanese and Chinese adults to check its safety and how the body processes it. Participants must be first-generation born in Japan or China. The study does not aim to treat any disease, so there is no direct heal…
Phase: PHASE1 • Sponsor: Jade Biosciences, Inc. • Aim: Knowledge-focused
Last updated May 12, 2026 13:40 UTC